 |
FSD Pharma
HUGE
|
2.94 K |
- |
5743.5 % |
$ 69.7 M |
Canada |
 |
Compugen Ltd.
CGEN
|
400 |
$ 2.02 |
-0.98 % |
$ 189 M |
Israel |
 |
Happiness Biotech Group Limited
HAPP
|
29 |
- |
1.35 % |
$ 17.8 M |
China |
 |
Coherus BioSciences
CHRS
|
559 |
$ 1.42 |
- |
$ 166 M |
USA |
 |
AgeX Therapeutics
AGE
|
186 |
- |
-10.17 % |
$ 12.2 K |
USA |
 |
I-Mab
IMAB
|
271 |
- |
- |
$ 866 M |
China |
 |
Deciphera Pharmaceuticals
DCPH
|
60.8 |
- |
- |
$ 2.18 B |
USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
84.7 |
- |
- |
$ 40.3 B |
USA |
 |
Alpine Immune Sciences
ALPN
|
1.73 |
- |
- |
$ 2.17 B |
USA |
 |
CureVac N.V.
CVAC
|
13.6 |
- |
- |
$ 867 M |
Germany |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.75 K |
- |
-1.52 % |
$ 24.7 M |
USA |
 |
Midatech Pharma plc
MTP
|
204 |
- |
-18.52 % |
$ 27.3 M |
Britain |
 |
Affimed N.V.
AFMD
|
31.4 |
- |
-34.95 % |
$ 21.5 M |
Germany |
 |
CRISPR Therapeutics AG
CRSP
|
1.1 K |
$ 51.48 |
-0.23 % |
$ 4.63 B |
Schweiz |
 |
Celyad Oncology SA
CYAD
|
64.4 |
- |
- |
$ 12.5 M |
Belgium |
 |
Berkeley Lights
BLI
|
103 |
- |
-7.31 % |
$ 87 M |
USA |
 |
Celldex Therapeutics
CLDX
|
321 |
$ 29.6 |
3.64 % |
$ 1.97 B |
USA |
 |
Generation Bio Co.
GBIO
|
47.6 |
- |
- |
$ 344 M |
USA |
 |
Ayala Pharmaceuticals
AYLA
|
61.7 |
- |
- |
$ 7.46 M |
Israel |
 |
Cyclacel Pharmaceuticals
CYCCP
|
3.66 K |
- |
-4.36 % |
$ 27 M |
USA |
 |
Anika Therapeutics
ANIK
|
76.5 |
$ 14.57 |
-0.21 % |
$ 209 M |
USA |
 |
Advaxis
ADXS
|
3.28 K |
- |
-9.65 % |
$ 45.9 M |
USA |
 |
Aeterna Zentaris
AEZS
|
146 |
- |
5.93 % |
$ 314 M |
Canada |
 |
Aeglea BioTherapeutics
AGLE
|
216 |
- |
- |
$ 1.01 B |
USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
126 |
- |
- |
$ 26.5 M |
USA |
 |
AIkido Pharma
AIKI
|
17.9 |
- |
1.93 % |
$ 17.4 M |
USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
28.1 |
$ 2.91 |
-5.52 % |
$ 4.79 M |
Israel |
 |
Aptinyx
APTX
|
46.9 |
- |
-39.0 % |
$ 4.57 M |
USA |
 |
Albireo Pharma
ALBO
|
14.7 |
- |
-0.23 % |
$ 916 M |
USA |
 |
Arcutis Biotherapeutics
ARQT
|
106 |
$ 22.79 |
5.8 % |
$ 2.9 B |
USA |